ABT
Abbott Laboratories·NYSE
--
--(--)
--
--(--)
ABT fundamentals
Abbott Laboratories (ABT) Revenue Breakdown: Q4 2025 Business & Regional Performance
Abbott Laboratories (ABT) reported total revenue of 11.45B USD in Q4 2025, with its core business segment Nutritionals contributing 16.94%. Regionally, United States remained the largest market, accounting for 38.25% of total revenue. Explore Abbott Laboratories's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Abbott Laboratories (ABT) reported total revenue of 11.45B USD in Q4 2025, with its core business segment Nutritionals contributing 16.94%. Regionally, United States remained the largest market, accounting for 38.25% of total revenue. Explore Abbott Laboratories's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What factors drove the changes in Abbott Laboratories's revenue and profit?What guidance did Abbott Laboratories's management provide for the next earnings period?What is Abbott Laboratories's gross profit margin?What were the key takeaways from Abbott Laboratories’s earnings call?What is the market's earnings forecast for Abbott Laboratories next quarter?What is Abbott Laboratories's latest dividend and current dividend yield?What is the revenue and EPS growth rate for Abbott Laboratories year over year?Did Abbott Laboratories beat or miss consensus estimates last quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
